Unilateral pneumonectomy leads to compensatory growth in the residual lung, the mediators of which are largely unknown. We hypothesized, based on its other known roles in lung cell growth, that platelet-derived growth factor (PDGF)-BB would be an essential mediator of postpneumonectomy compensatory lung growth. Left-sided pneumonectomies were performed on 21-dold rats, for comparison with sham-operated or unoperated control animals. Body weights were not different between groups. Right lung weights and DNA content were significantly increased (p Ͻ 0.05), compared with controls, by 10 d after pneumonectomy. The rate of DNA synthesis was maximal on d 5 postpneumonectomy. Total right lung PDGF-B mRNA and PDGF-BB protein increased after pneumonectomy, but were apparently tightly regulated, relative to total right lung ␤-actin mRNA and protein content, respectively. However, PDGF-BB expression after pneumonectomy was apparently not purely constitutive, in that daily i.p. injections of a truncated soluble PDGF ␤-receptor both reduced activation of the native PDGF ␤-receptor, and attenuated increased lung DNA synthesis on d 3 after pneumonectomy. These findings are consistent with a critical role for PDGF-BB in postpneumonectomy lung growth. Children and adolescents subjected to a unilateral pneumonectomy develop a varying degree of compensatory growth in the contralateral lung (1). Extensive animal studies have enhanced our understanding of this process (2-7). The degree of compensatory growth achieved is reduced with age, but, if lung tissue is removed sufficiently early in life, there is an almost complete restitution of air space, capillary and tissue volumes, and alveolar and capillary surface areas to normal (8, 9). Physiologic, pathophysiological, and morphologic studies suggest that, at least in small animal species, this compensatory growth occurs within the first 2 wk after surgery (5, 6, 10). Cellular hyperplasia is evident during compensatory lung growth (10, 11), with increased mitotic indices of parenchymal cells, total DNA, and DNA synthesis (as measured by incorporation of [ 3 H]thymidine) having been observed in rats (10 -13), mice (14), and rabbits (6).
Children and adolescents subjected to a unilateral pneumonectomy develop a varying degree of compensatory growth in the contralateral lung (1) . Extensive animal studies have enhanced our understanding of this process (2) (3) (4) (5) (6) (7) . The degree of compensatory growth achieved is reduced with age, but, if lung tissue is removed sufficiently early in life, there is an almost complete restitution of air space, capillary and tissue volumes, and alveolar and capillary surface areas to normal (8, 9) . Physiologic, pathophysiological, and morphologic studies suggest that, at least in small animal species, this compensatory growth occurs within the first 2 wk after surgery (5, 6, 10) .
Cellular hyperplasia is evident during compensatory lung growth (10, 11) , with increased mitotic indices of parenchymal cells, total DNA, and DNA synthesis (as measured by incorporation of [ 3 H]thymidine) having been observed in rats (10 -13), mice (14) , and rabbits (6) .
Successful postpneumonectomy lung growth is likely to require the coordinated expression of various growth factors and their receptors, directed at the different cell types within the lung (15) , acting through autocrine, endocrine, juxtacrine, or paracrine pathways. Despite an extensive literature relating to experimental pneumonectomy, the mediators of compensatory growth in the residual lung tissue have not been elucidated. It has been shown that the immediate-early genes c-fos and jun-B are up-regulated very rapidly (30 min) after pneumonectomy (16) . However, the downstream events that follow this early response, and mediate the proliferative response, are not clear. It has been suggested that tumor necrosis factor may be one of the hormonal factors implicated in postpneumonec-tomy lung growth (17) . IGF-I does not appear to be an endocrine growth factor after pneumonectomy in rabbits (18) . Altered expression of IGF-I has been both reported to play (19) , and not play (20) , a role in postpneumonectomy lung growth in rats. An increase in IGF-I has been reported after pneumonectomy in lambs (21) . Serum concentrations of hepatocyte growth factor increase after pneumonectomy in adult humans (22) .
Other growth factors involved in compensatory lung growth after pneumonectomy, including the PDGF-BB homodimer,
have not yet, to our knowledge, been studied. PDGF-BB is well recognized to play a critical role in early lung development (23, 24) , and to be up-regulated during lung injury (25) . Based on our previous observations that PDGF-BB mediates stretch-induced fetal lung cell proliferation in vitro (26) , and the probable role of tissue expansion in initiating compensatory lung growth (7), we hypothesized that PDGF-BB would also be a critical mediator in vivo for postpneumonectomy compensatory lung growth.
METHODS

Materials.
Radioisotopes were from ICN Radiochemicals (Irvine, CA, U.S.A.), nylon membranes and RNAguard were from Amersham Canada (Oakville, Ontario, Canada), and restriction enzymes and dextran sulfate were from Pharmacia (Baie D'Urfé, Québec, Canada). BSA type V, Ficoll 400, polyvinylpyrrolidone, guanidinium thiocyanate, cesium chloride, poly(L-lysine), PMSF, and salmon sperm DNA were from Sigma Chemical (St. Louis, MO, U.S.A.). A genomic DNA isolation reagent (DNAzol) was from Molecular Research Center (Cincinnati, OH, U.S.A.). Protein assay kits were from Bio-Rad (Hercules, CA, U.S.A.). ECL Western blotting detection reagents were from Amersham Life Science (Little Chalfont, Buckinghamshire, U.K.). Fluorescent dye (Hoescht 33258) was from Polysciences (Warrington, PA, U.S.A.). Enflurane (Ethrane), the inhalation anesthetic, was from Zeneca Pharma (Mississauga, Ontario, Canada). Ketamine, atropine, and pentobarbital (Euthanyl) were from MTC Pharmaceuticals (Cambridge, Ontario, Canada), and acepromazine (Atravet) from Ayerst Laboratories (Montreal, Québec, Canada). Buprenorphine, for postoperation pain relief, was from Reckitt & Colman Products (Hull, England). Organic solvents were of HPLC grade. Porcine trypsin (1:250), proteinase K, and ribonuclease (RNase)-A were from Invitrogen Canada (Burlington, Ontario, Canada). Rabbit anti-human PDGF-BB polyclonal IgG was from Genzyme (Cambridge, MA, U.S.A.). Rabbit anti-human PDGF-R␤ polyclonal IgG, mouse monoclonal IgG 2b antibody to phosphotyrosine (PY99), and goat antimouse monoclonal IgG conjugated with peroxidase were from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Goat anti-rabbit IgG conjugated with peroxidase was from Roche Molecular Biochemicals (Indianapolis, IN, U.S.A.). Human recombinant PDGF-BB was from Upstate Biotechnology (Lake Placid, NY, U.S.A.). A kit for avidin-biotin peroxidase complex immunocytochemical staining was purchased from Vector Laboratories (Burlingame, CA, U.S.A.). ␣-Aminopropyl-triethoxysilane and the Fc fragment of goat anti-human IgG were from Pierce Chemical (Rockford, IL, U.S.A.). Human PDGF-R␤/Fc and NGF-R␤/Fc chimeras, soluble truncated receptors for PDGF-BB and NGF, respectively, were purchased from R & D Systems (Minneapolis, MN, U.S.A.). Goat IgG (Fc) was from Serotec (Raleigh, NC, U.S.A.).
Pneumonectomy. All procedures involving animals were conducted according to criteria established by the Canadian Council for Animal Care, and prior approval was obtained from the Animal Care Review Committee at the Hospital for Sick Children Research Institute. Left unilateral pneumonectomies were performed on Wistar rat pups at 21 d of age. The pups were premedicated with a mixture of ketamine (14.7 mg/kg), atropine (22.5 g/kg), and acepromazine (0.3 mg/kg), then intubated under direct vision using a size-fit cannula. They were connected to a BP-200 volume-cycled infant pressure ventilator (Bourns Medical Systems, Riverside, CA, U.S.A.), delivering a tidal volume of 10 mL/kg at a rate of 75-80 breaths/min. The left side of the chest was shaved and sterilized with 75% (vol/vol) ethanol. An incision was made in the fifth left intercostal space and the pleural cavity was opened under 0.75% (vol/vol) enflurane general anesthesia. The ECG was monitored during operation with a 78534A monitor from Hewlett Packard (Palo Alto, CA, U.S.A.). Blood oxygen saturation was continuously monitored with an N-100 pulse oximeter (Nellcor Inc., Hayward, CA, U.S.A.). The exposed left lung was exteriorized using blunt forceps. The hilum was then clamped and ligated and the lung was removed. The thoracic cavity was then closed with two layers of sutures. After removal of the lung, intermitted positive-pressure ventilation with 100% O 2 was briefly maintained to ensure adequate inflation of the right lung. Intramuscular buprenorphine (0.5 mg/kg) was used to provide postoperative analgesia. Shamoperated control pups were treated similarly to the pneumonectomized animals, except that the lung was not removed after puncturing the plural cavity. An additional control group received premedication only. Lung and body weights were recorded at 3, 5, 7, and 10 d after pneumonectomy.
Lung DNA content and [ 3 H]thymidine incorporation into DNA. Under anesthesia, the chest was opened and lungs were removed and immediately frozen in liquid nitrogen. Weighed aliquots of lung tissues were homogenized with a Polytron (PT-10 Ϫ35 , Kinematica GmbH, Littau, Switzerland) in lysis buffer [100 mM NaCl, 10 mM Tris, 25 mM EDTA, 0.5% (vol/vol) SDS; pH 8.0] and incubated overnight at 50°C in the presence of proteinase K (0.1 mg/mL). For quantitative measurement, DNA was then extracted with an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1, vol/vol/vol) and precipitated by adding a half volume of 7.5 M ammonium acetate and two volumes of 100% (vol/vol) ethanol (27) . DNA concentrations were measured, after the samples were diluted to the linear range of a standard curve (0.01-1 g/mL), using a fluorescent dye technique (28 Isolation of lung RNA. Briefly, the thoracic contents were removed en bloc and the lungs dissected away from vessels and large airways to be flash frozen in liquid nitrogen. Weighed lung tissue samples were homogenized in a denaturing solution containing 4 M guanidium thiocyanate, and total (nuclear and cytoplasmic) RNA was isolated following the method of Chomczynski and Sacchi (30) . After extraction with phenol/ chloroform (1:1, vol/vol) the RNA was ethanol precipitated and collected by centrifugation. This RNA was lyophilized and dissolved in 0.02% (vol/vol) diethyl pyrocarbonate-treated water. All RNA samples were stored at Ϫ70°C in the presence of a RNase inhibitor, RNAguard (0.15 U/g RNA). Integrity of RNA was assessed visually after fractionation on 1.2% (wt/ vol) agarose-formaldehyde gels from the appearance of the 28 and 18S ribosomal RNA bands stained with ethidium bromide.
Generation of PCR probes. Total RNA was isolated and reverse transcriptase PCR was performed as previously described (31) . The amplified PCR products were then gelpurified and ligated into PCR II (Invitrogen, San Diego, CA, U.S.A.) with T4 DNA ligase. After transformation of competent Escherichia coli, several colonies were picked for sequence analysis using the dideoxy chain termination method (Pharmacia) according to the manufacturer's instructions. Sequence analysis showed a Ͼ95% homology to the published sequence. The primers for PDGF-B, 5'-AGTCGGCAT-GAATCGCTGCTGGG-3' and 5'-TTTCTCACCTGGACCG-GCCGCAT-3', were based on the murine genomic sequence (32) and when amplified gave a fragment of 476 bp. The primers for PDGF-R␤, 5'-CGACGATTCCATGCCGAGT-GACA-3' and 5'-AGTGGACAGAACCAACTCGCC-3', were based on a rat cDNA sequence (Genbank number: RNDP-DGRRBE), giving a 654 bp fragment. The primers for rat ␤-actin, 5'-TTGTAACCAACTGGGACGATATGG-3' and 5'-GATCTTGATCTTCATGGTGCTAGG-3', were based on the rat genomic sequence (33) and when amplified gave a fragment of 764 bp. The reverse transcriptase PCR-generated cDNAs were excised from PCR II plasmids by restriction digestion, labeled with [␣-32 P]dCTP by random hexamer priming and used as hybridization probes.
Northern blot analysis. All Northern blot analyses were performed as previously described (34), using 20 g of RNA.
The total RNA samples were denatured in a loading buffer containing 3.2 M formaldehyde for 5 min at 65°C and electrophoresed in 1.2% (wt/vol) agarose gels containing 0.66 M formaldehyde. The RNAs were transferred to Hybond-N ϩ nylon membrane (Amersham Health, Arlington Heights, IL, U.S.A.) using the capillary transfer technique. After transfer, the blots were air dried and fixed in a UV cross-linker (Stratagene, La Jolla, CA, U.S.A.). All probes were labeled with deoxycytidine 5'-[␣- 32 P]triphosphate by a random primed labeling system (Amersham Health), with specific activities of 0.5-2.9 ϫ 10 9 counts ϫ min Ϫ1 ϫ g DNA
Ϫ1
. Prehybridization (5 h) and hybridizations (Ͼ16 h) at 42°C were performed in 50% (vol/vol) formamide; 750 mM NaCl; 75 mM sodium citrate; ϫ5 Denhardt's solution [ϭ 0.1% (wt/vol) each of BSA, Ficoll, and polyvinylpyrrolidone]; 10% (wt/vol) dextran sulfate; and 100 g/mL denatured salmon sperm DNA. Washes varied with the probe used. PDGF-B blots were twice washed in 2 ϫ SSC (ϭ 300 mM NaCl, 30 mM sodium citrate, pH 7.0) and 0.1% (wt/vol) SDS for 10 min at room temperature, followed by a more stringent wash in 1 ϫ SSC and 0.2% (wt/vol) for 2-5 min at 42°C. Blots hybridized with the PDGF-R␤ were washed in 2 ϫ SSC and 0.1% (wt/vol) for 10 min at room temperature followed by a second, more stringent wash in 1 ϫ SSC and 0.2% (wt/vol) SDS for 2 min at 42°C. After stripping, blots were hybridized with the ␤-actin probe (33), then washed in 2 ϫ SSC and 0.1% (wt/vol) for 10 min at room temperature followed by a second, more stringent wash in 1 ϫ SSC and 0.2% (wt/vol) for 2 min at 42°C. The blots were exposed for 24 -48 h at Ϫ70°C to Kodak XAR-5 film (Eastman Kodak, Rochester, NY, U.S.A.) using DuPont Cronex intensifying screens (DuPont, Wilmington, DE, U.S.A.). The films were quantified by an Ultroscan XL laser densitometer (LKB, Uppsala, Sweden), and results expressed as arbitrary units (AU) per sample . For calculations of mRNA content in whole lung, PDGF-B and PDGF-R␤ mRNA values were corrected for sample dilution. To compensate for variations in RNA transfer, all results were normalized against the d-0 control values for individual gels.
Autoradiography and immunohistochemistry. Animals received [
3 H]thymidine (1 mCi/kg, i.p.) 2 h before sacrifice. They were deeply anesthetized with pentobarbital (200 mg/kg). A tracheal catheter was inserted and sutured in place to facilitate lung inflation. The anterior part of the chest wall was reflected upward. While the heart was beating, a 23-gauge needle was inserted through the right ventricle, and an incision made in the left atrial appendage to allow drainage. The pulmonary circulation was then flushed with PBS containing 1 U/mL heparin, during intermittent lung inflation, until the lungs became white. The lungs were subsequently fixed by perfusion with freshly prepared 4% (wt/vol) paraformaldehyde under a constant airway pressure of 12 cm H 2 O. The middle lobe of the right lung was embedded in paraffin and cut in 5-m sections. Sections were mounted on ␣-aminopropyltriethoxysilane-coated slides.
Slides were coated with Kodak NBT-3 emulsion and developed after 4 wk at 4°C for autoradiography. The slides were lightly counterstained with Carazzi hematoxylin. Cells undergoing active DNA synthesis were identified by the presence of silver granules over cell nuclei, with positive labeling being defined according to the criteria of Chwalinski et al. (35) . A total of five random microscope fields (ϫ400 magnification) were counted from each of two animals at each time point. Because only two animals were used for each data point, a second set of animals was similarly studied to show reproducibility of results.
Immunohistochemistry studies were conducted using an avidin-biotin-peroxidase complex method (36) . Dilutions of the primary antisera were 1:200 for PDGF-BB (rabbit anti-human IgG) and 1:1200 for PDGF-R␤ (rabbit anti-human IgG). Dilutions for secondary antisera, goat anti-rabbit IgG conjugated with peroxidase, were 1:200 and 1:600, respectively. Slides were lightly counter-stained with Carazzi hematoxylin, dehy-27 PNEUMONECTOMY AND PDGF-BB EXPRESSION drated, cleared in xylene, and mounted. Three animals were studied for each time point. Slides from different groups were processed in parallel. Illustrations represent findings evident in all three animals.
Western blot analysis. Lung tissues were homogenized with five volumes of lysis buffer containing 1% (vol/vol) NP40, 0.5% (wt/vol) sodium deoxycholate, 0.1% (wt/vol) SDS, and 100 g/mL PMSF in PBS. The homogenate was left on ice for 30 min before centrifugation at 10,000 ϫ g. Protein content was estimated according to the method of Bradford (37) . Aliquots of 100 g of homogenate protein were diluted with sample buffer containing 125 mM Tris, 20% (wt/vol) glycerol, and 4% (wt/vol) SDS and separated on 15% (wt/vol) polyacrylamide gels with 0.1% (vol/vol) SDS. Proteins were subsequently transferred to a nitrocellulose membrane. Nonspecific binding was blocked by incubation with 5% (vol/vol) normal goat serum and 1% (wt/vol) BSA in PBS for 1 h at 20°C with shaking, followed by overnight incubation with a 1:500 (vol/vol) dilution of primary antibody of rabbit antihuman PDGF-BB, or a 1:250 (vol/vol) dilution of primary antibody of rabbit anti-human PDGF-R␤. Membrane was subsequently incubated with 1:30,000 (vol/vol) dilution, for PDGF-BB, or a 1:20,000 (vol/vol) dilution, for PDGF-R␤, of goat anti-rabbit IgG conjugated with peroxidase for 1 h at 20°C. For calculations of protein content in whole lung, PDGF-BB values were corrected for sample dilution. To compensate for variations in transfer, all results were normalized against the d-0 control values for individual gels. For the study of receptor phosphorylation, samples were obtained from paired litter mates, derived from four separate litters. A mouse monoclonal IgG for phosphotyrosine (PY99) was diluted to 1:100,000, with the secondary antisera of goat anti-mouse IgG diluted to 1:2000. Between each incubation step, the membrane was thoroughly washed with cold PBS (10 min ϫ 3) . The peroxidase reaction was carried out using ECL Western blotting detection reagents.
Inactivation of PDGF-BB with PDGF-R␤/Fc. Bioactivity of the PDGF-R␤/Fc chimera was initially confirmed in vitro by attenuation of PDGF-BB-mediated enhancement of DNA synthesis by fetal rat lung distal epithelial lung cells, but no independent effect on DNA synthesis (data not shown). The PDGF-R␤/Fc was injected i.p. (Ϸ0.6 mg/kg) immediately after pneumonectomy, then daily for 48 h. This concentration was based on preliminary experiments to define maximal inhibitory effects (data not shown). The PDGF-R␤/Fc chimera was dissolved in 0.2% (wt/vol) BSA in PBS. Control experiments, to exclude nonspecific effects, were conducted using Ϸ0.6 mg/kg of either an NGF-R/Fc chimera or the Fc fragment of goat IgG.
Data presentation. Unless otherwise stated, all numerical values are shown as mean Ϯ SEM of four litters for each time point. Statistical significance (p Ͻ 0.05) was determined by an ANOVA followed by assessment of differences using Duncan's multiple range test (38) or a paired t test (39) . SE bars are not evident for all data points shown in the figures because they fall within the plot point.
RESULTS
Pneumonectomy, or sham operation, had no adverse effect on gains in body weight, relative to control rats (Table 1) . Sham operation had no effect on lung weights (Table 2) . Significantly increased (p Ͻ 0.05) right lung weights were observed in the pneumonectomized group as early as d 3 postpneumonectomy (Table 2) . Right lung DNA content progressively increased to d 10 after pneumonectomy (Ϸ3-fold Body weights of unoperated animals (control) were compared with those of animals subjected to sham-operation or pneumonectomy on d 21 of life (d 0). Values are means Ϯ SEM from four animals in each group. No differences were seen among groups (p Ͼ 0.05 by ANOVA). (Fig. 1) . No significant increase in labeling of DNA with time was evident in the lungs of either control or sham-operated animals.
Table 2. Effect of left pneumonectomy on right and combined lung weights
As shown in Figure 2 , total PDGF-B mRNA content in the right lung, expressed as AU, significantly increased (p Ͻ 0.05) from d 5 to d 10 after pneumonectomy (lower panel). However, these changes in mRNA expression were no longer evident when PDGF-B mRNA content was normalized for ␤-actin mRNA content (upper and middle panels), or expressed against ribosomal RNA (data not shown). An essentially similar pattern was observed with replicate analyses of the PDGF-R␤ mRNA (data not shown). These findings are consistent with a tightly regulated increase in mRNA content in proportion to the increase in lung mass.
Consistent with the mRNA findings, total immunoreactive PDGF-BB content in the right lung increased (p Ͻ 0.05) with lung growth on d 7 and 10 after pneumonectomy (Fig. 3A) . However, this also appeared to be tightly regulated, maintaining a constant PDGF-BB content when expressed as U/mg protein (Fig. 3B ). In keeping with the Western analysis, PDGF-BB immunohistochemistry did not reveal any obvious gross difference in total immunoreactivity or distribution of immunoreactivity among control, sham-operated, and pneumonectomized groups. Figure 4 is an illustration of immunostaining from d 7 animals. A similar lack of any differences between groups was also evident for PDGF-R␤ immunoreactivity (Fig.  5) . Similar findings were observed at all time points studied (d 3, 5, 7, and 10). 
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The lack of any obvious change in mRNA or protein for PDGF-BB or PDGF-R␤, after normalization, was consistent with a simple correction to prepneumonectomy constitutive values, but did not rule out a role for PDGF-BB and its receptor in compensatory growth. Intervention with a soluble receptor was used to determine whether PDGF-BB did have such a role. Binding of the soluble receptor to endogenous PDGF-BB prevents binding of this ligand to its natural receptor, and receptor activation. This should inhibit any PDGF-BBmediated compensatory lung growth. Intraperitoneal injection of the PDGF-R␤/Fc chimera resulted in a reduction of pulmonary PDGF-BB immunoreactivity (Fig. 6) , confirming that i.p. injection allowed an adequate delivery of the PDGF-R␤/Fc chimera to the lung. Slides were also stained for endothelin-1 (an arbitrary choice for a control ligand) to exclude a nonspecific blocking effect, and no differences were observed between groups (data not shown). Four animals each received either i.p. PDGF-R␤/Fc chimera or vehicle for 3 consecutive days after pneumonectomy. Western blot analysis (Fig. 7A ) was used to confirm that binding of the truncated PDGF-R␤/Fc chimera soluble receptor to PDGF-BB inhibited activation of the native pulmonary PDGF-R␤. A significant (p Ͻ 0.05) reduction in immunoreactive PDGF-R␤ tyrosine phosphorylation was evident in the lungs of animals that had received the PDGF-R␤/Fc chimera (Fig. 7B) . No significant reduction (p Ͼ 0.05) was observed in control animals injected with NGF-R/Fc chimera (Fig. 8A) , and DNA content (Fig. 8B) , were arrested by i.p. injection of the PDGF-R␤/Fc chimera, but not the control NGF-R/Fc chimera. Additional animals were injected with the Fc portion of IgG alone, which had no effect on lung DNA synthesis (data not shown). Changes in gross lung weights were less sensitive than measurements of DNA content or of [ 3 H]thymidine incorporation into DNA. Right lung weights in control animals were 345 Ϯ 28 mg increasing to 402 Ϯ 19 mg with pneumonectomy. This increase in weight with pneumonectomy was reduced by Ϸ50% with i.p. injection of the PDGF-R␤/Fc chimera (371 Ϯ 9 mg), which did not achieve statistical significance (p Ͼ 0.05), but not with i.p injection of the NGF-R/Fc chimera (414 Ϯ 15 mg).
These data could be consistent with an early (Ͻ 3 d) increase in PDGF-B and/or PDGF-R␤ mRNA, and protein for PDGF-BB and/or the PDGF-R␤, which would not have been detected at the 3-, 5-, 7-, and 10-d time points previously examined. Additional lung tissues from animals was therefore obtained for comparable analysis at 1 d after pneumonectomy. This time point was selected because a significant increase in DNA synthesis was already evident at 2 d (Fig. 1) . As with the later time points, no differences between groups were evident (data not shown).
DISCUSSION
The pneumonectomy model selected for use in these studies is a modification of that reported by Holmes and Thurlbeck (9) , except that we performed pneumonectomies at an earlier time point, in an effort to achieve the maximum possible signal for compensatory lung growth. This was well tolerated, with no inhibition of body weight gain following surgery. As would be predicted from previously reported studies, compensatory cell division in the residual lung was complete by 10 d after 
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PNEUMONECTOMY AND PDGF-BB EXPRESSION pneumonectomy, as assessed by a measurement of DNA synthesis. We did not conduct a morphometric analysis, but pneumonectomy in young rats has been shown by others to be associated with an increase in alveolar number in the residual lung (9) .
In agreement with earlier studies (5, 40) , both DNA content in the right lung and [ 3 H]thymidine incorporation into DNA were significantly increased after pneumonectomy. DNA content in the right lung continuously increased postpneumonectomy. Sham operation may have caused a small early effect on DNA content, although this was not statically significant, consistent with a minor stimulatory effect after collapse of the lung. Increased DNA synthesis was an early event after pneumonectomy, being significantly increased as early as d 2 after surgery, with peak activity at d 5 and a significantly increased rate of DNA synthesis still evident at d 7.
We hypothesized that PDGF-BB activation of the PDGF-R␤ would be a mediator of postpneumonectomy compensatory lung growth. Consistent with this hypothesis was an increase in the total PDGF-B mRNA and PDGF-BB content in the residual lung after pneumonectomy. However, no increase was evident when these values were normalized against ␤-actin and milligrams of protein, respectively, consistent with their expression being tightly regulated. It was therefore possible that the late increases observed in the residual lung 7 and 10 d after pneumonectomy were simply a reflection of a constitutive normalization of tissue content, without PDGF-BB or its receptor being actively involved in compensatory lung growth.
That activation of the PDGF-R␤ by PDGF-BB was of importance in the process of compensatory lung growth was revealed by the use of a truncated soluble receptor (PDGF-R␤/Fc chimera) approach. We have previously used this approach to demonstrate a critical role for PDGF-BB in normal postnatal lung growth in the newborn rat (34) . The soluble receptor bound to PDGF-BB, both reducing its accessibility to antibody and limiting its potential for binding and activation of its native PDGF-R␤ in vivo. This, in turn, attenuated the increase in DNA synthesis and DNA mass normally evident in the residual lung after pneumonectomy. Lack of effect in either NGF-R/Fc chimera-or IgG (Fc)-injected controls suggested a specific effect of the PDGF-R␤/Fc chimera on binding of PDGF-BB to the PDGF-R␤. An effect through binding of the PDGF-R␤/Fc chimera to other forms of PDGF can be excluded, inasmuch as neither PDGF-AA nor PDGF-AB bind with high affinity to the PDGF-R␤ (41) . What our data does not allow us to absolutely exclude is an effect of PDGF-BB on the PDGF ␣-receptor, which can bind all PDGF isoforms. However, this seems unlikely to account for the observed effect, in that binding of PDGF-BB by the PDGF-R␤/Fc chimera would leave binding of PDGF-AA to the PDGF ␣-receptor unopposed and would not prevent PDGF ␣-receptor-mediated signaling.
We have not specifically assessed the cell types responsive to PDGF-BB by increased DNA synthesis in this model. Both alveolar epithelial cells and small vessel endothelial cells expressed the PDGF-R␤, and are likely targets. Microvascular endothelial cells from developing lung increase DNA synthesis in response to PDGF-BB (42) . Isolated type II pneumocytes from animals of a similar age also respond to PDGF-BB with an increase in DNA synthesis, unlike type II pneumocytes from completely mature animals, which are unresponsive (43) .
In summary, there are apparently tightly regulated increases in residual lung PDGF-B mRNA and PDGF-BB over the first 10 d following pneumonectomy, which occur in parallel with a compensatory increase in lung DNA content. This could simply reflect a constitutive increase in PDGF-B mRNA and PDGF-BB, unrelated to an increase in DNA synthesis. However, our data do support a critical role for PDGF-BB in early compensatory lung growth in the rat after pneumonectomy. A pharmacological intervention with a truncated PDGF-R␤/Fc soluble receptor has allowed us to demonstrate a causal relationship between PDGF-BB and postpneumonectomy compensatory DNA synthesis. This observation also brings into question the assumption that no increase in normalized growth factor mRNA or protein, after pneumonectomy, automatically excludes a role in compensatory growth, as reported for IGF-I (20) .
